Berberine users sometimes report digestive upset (bloating, diarrhea, constipation), which can overlap with common GLP-1 side effects like nausea and appetite changes
The first month was rough
Mounjaro Mounjaro is another injectable medication approved for use in treating adults with type 2 diabetes
It acts by delaying gastric emptying, decreasing food intake, and helps regulate blood sugars by affecting hormones such as insulin and glucagon. Glucagon and insulin are both hormones that balance blood sugar levels
Common causes include gallstones, excessive alcohol consumption, certain medications, hypertriglyceridaemia, and anatomical abnormalities
Effects typically become more pronounced as the dose increases during the 16-week titration period, with peak appetite control often occurring around weeks 16-20 of treatment